These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 27343040

  • 1. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
    Djurić-Jovičić M, Petrović I, Ječmenica-Lukić M, Radovanović S, Dragašević-Mišković N, Belić M, Miler-Jerković V, Popović MB, Kostić VS.
    J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
    [Abstract] [Full Text] [Related]

  • 2. Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.
    Ling H, Massey LA, Lees AJ, Brown P, Day BL.
    Brain; 2012 Apr; 135(Pt 4):1141-53. PubMed ID: 22396397
    [Abstract] [Full Text] [Related]

  • 3. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [Abstract] [Full Text] [Related]

  • 4. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M.
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [Abstract] [Full Text] [Related]

  • 5. Posturographic abnormalities in ambulatory atypical parkinsonian disorders: Differentiating characteristics.
    Panyakaew P, Anan C, Bhidayasiri R.
    Parkinsonism Relat Disord; 2019 Sep; 66():94-99. PubMed ID: 31337595
    [Abstract] [Full Text] [Related]

  • 6. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J, Bonnet C, Klempíř J, Tykalová T, Baborová E, Novotný M, Rulseh A, Růžička E.
    J Neurol; 2015 Sep; 262(4):992-1001. PubMed ID: 25683763
    [Abstract] [Full Text] [Related]

  • 7. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC.
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [Abstract] [Full Text] [Related]

  • 8. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW, Tucha O, Alders GL, Preier M, Csoti I, Merz B, Mark G, Herting B, Fornadi F, Reichmann H, Vieregge P, Reiners K, Becker G, Naumann M.
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Takao Y, Ohta T, Manabe Y, Sato S, Abe K.
    Intern Med; 2011 Sep; 50(22):2775-81. PubMed ID: 22082889
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O, Gorges M, Müller HP, Pinkhardt EH, Ludolph AC, Huppertz HJ, Kassubek J.
    Neurodegener Dis; 2017 Sep; 17(4-5):117-126. PubMed ID: 28268209
    [Abstract] [Full Text] [Related]

  • 15. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ, Siuda J.
    Neurol Neurochir Pol; 2024 Sep; 58(2):193-202. PubMed ID: 38148738
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P, Zhang J, Han J, Ji Y.
    Brain Behav; 2022 Dec; 12(12):e2827. PubMed ID: 36409061
    [Abstract] [Full Text] [Related]

  • 17. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
    Williams DR, Lees AJ.
    Mov Disord; 2010 Feb 15; 25(3):357-62. PubMed ID: 20108379
    [Abstract] [Full Text] [Related]

  • 18. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
    Mangesius S, Mariotto S, Ferrari S, Pereverzyev S, Lerchner H, Haider L, Gizewski ER, Wenning G, Seppi K, Reindl M, Poewe W.
    Parkinsonism Relat Disord; 2020 Aug 15; 77():57-63. PubMed ID: 32622301
    [Abstract] [Full Text] [Related]

  • 19. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M, Hayashi M, Hirai S.
    Rinsho Shinkeigaku; 1997 Jun 15; 37(6):476-82. PubMed ID: 9366173
    [Abstract] [Full Text] [Related]

  • 20. A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.
    Watanabe Y, Suzuki K, Miyamoto T, Miyamoto M, Numao A, Fujita H, Uchiyama T, Kadowaki T, Matsubara T, Hirata K.
    Intern Med; 2017 Nov 01; 56(21):2871-2878. PubMed ID: 28943542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.